BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34326345)

  • 1. Gastro-oesophageal reflux disease.
    Fass R; Boeckxstaens GE; El-Serag H; Rosen R; Sifrim D; Vaezi MF
    Nat Rev Dis Primers; 2021 Jul; 7(1):55. PubMed ID: 34326345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory Heartburn: A Challenging Problem in Clinical Practice.
    Domingues G; Moraes-Filho JPP; Fass R
    Dig Dis Sci; 2018 Mar; 63(3):577-582. PubMed ID: 29352757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease (GERD) in children.
    Poddar U
    Paediatr Int Child Health; 2019 Feb; 39(1):7-12. PubMed ID: 30080479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
    Tack J; Fass R
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of acid gastro-oesophageal reflux disease in Jackhammer oesophagus.
    Mallet AL; Ropert A; Bouguen G; Siproudhis L; Boutroux D; Bretagne JF; Brochard C
    Dig Liver Dis; 2016 Oct; 48(10):1136-41. PubMed ID: 27453169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management.
    Argüero J; Sifrim D
    Nat Rev Gastroenterol Hepatol; 2024 Apr; 21(4):282-293. PubMed ID: 38177402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.
    Ang D; How CH; Ang TL
    Singapore Med J; 2016 Oct; 57(10):546-551. PubMed ID: 27779277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: diagnosis and investigation of gastro-oesophageal reflux disease in Japanese patients.
    Kusano M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():14-8. PubMed ID: 15575866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease: clinical features.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):417-20. PubMed ID: 16341946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the patient with incomplete response to PPI therapy.
    Kahrilas PJ; Boeckxstaens G; Smout AJ
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):401-14. PubMed ID: 23998978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
    Woodland P; Sifrim D
    Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.